Browse 18 Life Science companies funded by Wellington Management. See funding amounts, founder contacts, and investment details.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.
Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
View all companies funded by Wellington Management across every industry and funding stage.
View Full Wellington Management Portfolio